These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11265407)

  • 1. [A case of primary malignant hemangiopericytoma of the lung with marked response to combination chemotherapy with cisplatin, ifosfamide and gemcitabine].
    Fujita A; Minase T; Takabatake H; Tagaki S; Sekine K
    Gan To Kagaku Ryoho; 2001 Mar; 28(3):373-6. PubMed ID: 11265407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract.
    Dodd PM; McCaffrey JA; Hilton S; Mazumdar M; Herr H; Kelly WK; Icasiano E; Boyle MG; Bajorin DF
    J Clin Oncol; 2000 Feb; 18(4):840-6. PubMed ID: 10673526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group.
    Rudd RM; Gower NH; Spiro SG; Eisen TG; Harper PG; Littler JA; Hatton M; Johnson PW; Martin WM; Rankin EM; James LE; Gregory WM; Qian W; Lee SM
    J Clin Oncol; 2005 Jan; 23(1):142-53. PubMed ID: 15625369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer.
    Sculier JP; Lafitte JJ; Lecomte J; Berghmans T; Thiriaux J; Florin MC; Efremidis A; Alexopoulos CG; Recloux P; Ninane V; Mommen P; Paesmans M; Klastersky J;
    Ann Oncol; 2002 Jun; 13(6):874-82. PubMed ID: 12123332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: a phase II study.
    Lin CC; Hsu CH; Huang CY; Keng HY; Tsai YC; Huang KH; Cheng AL; Pu YS
    Anticancer Drugs; 2007 Apr; 18(4):487-91. PubMed ID: 17351402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy of stage IV non-small-cell lung cancer: contribution of gemcitabine].
    Souquet PJ; Gérinière L
    Rev Pneumol Clin; 2000 Nov; 56(5):315-9. PubMed ID: 11139761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-finding study of fixed dose gemcitabine and escalating doses of ifosfamide given on days 1 and 8 in patients with advanced non-small cell lung cancer.
    Baka S; Manegold C; Buchholz E; Schott-von-Römer K; Lorigan P; Nagel S; Blackhall F; Aschroft L; Thatcher N
    Lung Cancer; 2006 Aug; 53(2):165-70. PubMed ID: 16787686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
    Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
    Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma.
    Pagliaro LC; Millikan RE; Tu SM; Williams D; Daliani D; Papandreou CN; Logothetis CJ
    J Clin Oncol; 2002 Jul; 20(13):2965-70. PubMed ID: 12089226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II trial of gemcitabine and ifosfamide in non-small cell lung cancer.
    Gatzemeier U; Manegold C; Eberhard W; Wilke HJ; Chomy F; Chomy P; Khayat D; Blatter J; Seeber S; Drings P
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-36-S8-38. PubMed ID: 9207315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy with gemcitabine with isolated lung perfusion for the treatment of pulmonary metastases.
    Van Putte BP; Hendriks JM; Romijn S; Pauwels B; Vermorken JB; Van Schil PE
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):125-30. PubMed ID: 15999051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project.
    Crinò L; Scagliotti GV; Ricci S; De Marinis F; Rinaldi M; Gridelli C; Ceribelli A; Bianco R; Marangolo M; Di Costanzo F; Sassi M; Barni S; Ravaioli A; Adamo V; Portalone L; Cruciani G; Masotti A; Ferrara G; Gozzelino F; Tonato M
    J Clin Oncol; 1999 Nov; 17(11):3522-30. PubMed ID: 10550150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine shows promise as combination agent in NSCLC.
    Oncology (Williston Park); 1996 Sep; 10(9):1311. PubMed ID: 9052981
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathological complete response to gemcitabine and cisplatin chemotherapy for advanced upper tract urothelial carcinoma: a case report].
    Matsuki M; Takahashi A; Katou S; Takayanagi A; Takagi Y; Kamata K
    Nihon Hinyokika Gakkai Zasshi; 2013 Jan; 104(1):33-7. PubMed ID: 23457933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliative treatment for advanced or metastatic osteosarcoma.
    Merimsky O; Kollender Y; Inbar M; Meller I; Bickels J
    Isr Med Assoc J; 2004 Jan; 6(1):34-8. PubMed ID: 14740508
    [No Abstract]   [Full Text] [Related]  

  • 16. A case report--The marked response to gemcitabine combined with irinotecan and low-dose cisplatin chemotherapy for advanced gastric cancer with multiple liver metastases.
    Teraishi F; Uno F; Kagawa S; Gochi A; Fujiwara T; Tanaka N
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1885-7. PubMed ID: 17212136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and future perspectives in advanced bladder cancer: is there a new standard?
    von der Maase H
    Semin Oncol; 2002 Feb; 29(1 Suppl 3):3-14. PubMed ID: 11894002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale.
    Gebbia V; Galetta D; Caruso M; Verderame F; Pezzella G; Valdesi M; Borsellino N; Pandolfo G; Durini E; Rinaldi M; Loizzi M; Gebbia N; Valenza R; Tirrito ML; Varvara F; Colucci G;
    Lung Cancer; 2003 Feb; 39(2):179-89. PubMed ID: 12581571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale of a phase III study comparing a standard cisplatin regimen (mitomycin/ifosfamide/cisplatin) with cisplatin and gemcitabine in non-small cell lung cancer.
    Tonato M; Crinó L; Mosconi AM
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-31-S8-35. PubMed ID: 9207314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer.
    Chen YM; Perng RP; Whang-Peng J; Wu HW; Lin WC; Tsai CM
    Lung Cancer; 2000 Dec; 30(3):199-202. PubMed ID: 11137205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.